Literature DB >> 16315251

Medical care utilization and mortality in sickle cell disease: a population-based study.

Sadhna M Shankar1, Patrick G Arbogast, Ed Mitchel, William O Cooper, Winfred C Wang, Marie R Griffin.   

Abstract

The purpose of this study was to evaluate the pattern of medical care utilization and mortality in children and adults with sickle cell disease (SCD) in the state of Tennessee. Rates of hospitalization, emergency department visits, and deaths were measured in a cohort of adults and children with SCD enrolled in TennCare, Tennessee's Medicaid managed health care program, from January 1995 to December 2002. TennCare data linked to Tennessee vital records were used to define the population and identify the outcomes. For children less than 5 years of age, the mortality rate was similar to that of other black Tennessee children (P = 0.71). Among children, the death rate was highest in 10-19 years of age and was 8-fold higher than Tennessee's race- and age-specific rate. Among 20- to 49-year-old patients with SCD, mortality was significantly higher in males than in females (P < 0.001). As compared to the black population without SCD in TennCare, patients with SCD had 7-30 times higher rate of hospitalization and 2-6 times higher rates of emergency department visits (P < 0.001). The death rate in adolescents and young adults with SCD continues to be much higher than population-specific rates. Interventions to prevent morbidity and mortality related to SCD are urgently needed. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16315251     DOI: 10.1002/ajh.20485

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  52 in total

1.  CE: Understanding the Complications of Sickle Cell Disease.

Authors:  Paula Tanabe; Regena Spratling; Dana Smith; Peyton Grissom; Mary Hulihan
Journal:  Am J Nurs       Date:  2019-06       Impact factor: 2.220

2.  Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007.

Authors:  Hussain R Yusuf; Hani K Atrash; Scott D Grosse; Christopher S Parker; Althea M Grant
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

3.  Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin.

Authors:  Sarah L Reeves; Hannah K Jary; Jennifer P Gondhi; Mary Kleyn; Kevin J Dombkowski
Journal:  Blood Adv       Date:  2019-05-28

4.  Exploring Adult Care Experiences and Barriers to Transition in Adult Patients with Sickle Cell Disease.

Authors:  C J Bemrich-Stolz; J H Halanych; T H Howard; L M Hilliard; J D Lebensburger
Journal:  Int J Hematol Ther       Date:  2015-09-06

5.  Sickle-cell disease in California: a population-based description of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2010-11-24       Impact factor: 3.167

6.  Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS), a focus group and decision support tool development project.

Authors:  Paula Tanabe; Christopher Reddin; Victoria L Thornton; Knox H Todd; Ted Wun; John S Lyons
Journal:  Acad Emerg Med       Date:  2010-08       Impact factor: 3.451

7.  Periodic limb movements and disrupted sleep in children with sickle cell disease.

Authors:  Valerie E Rogers; Carole L Marcus; Abbas F Jawad; Kim Smith-Whitley; Kwaku Ohene-Frempong; Cheryl Bowdre; Julian Allen; Raanan Arens; Thornton B A Mason
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

8.  Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.

Authors:  Robert E Molokie; Chariz Montminy; Corissa Dionisio; Muhammad Ahmen Farooqui; Michel Gowhari; Yingwei Yao; Marie L Suarez; Miriam O Ezenwa; Judith M Schlaeger; Zaijie J Wang; Diana J Wilkie
Journal:  Am J Emerg Med       Date:  2017-07-13       Impact factor: 2.469

9.  Ambulatory quality indicators to prevent infection in sickle cell disease.

Authors:  Lauren M Beverung; David Brousseau; Raymond G Hoffmann; Ke Yan; Julie A Panepinto
Journal:  Am J Hematol       Date:  2014-03       Impact factor: 10.047

10.  A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients.

Authors:  Patrick C Carroll; Carlton Haywood; Michelle R Hoot; Sophie Lanzkron
Journal:  Clin J Pain       Date:  2013-04       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.